




Healthcare Industry News: Sagent Pharmaceuticals
News Release - October 18, 2010
Sagent Pharmaceuticals Announces Launch of ANEclear Device for Rapid Clearance of Inhaled Anesthetics Following Surgery
SCHAUMBURG, Ill., Oct. 18 -- (Healthcare Sales & Marketing Network) -- Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced the commercial launch of ANEclear™, an easy-to-use, disposable anesthesia recovery device at the American Society of Anesthesia (ASA) meeting in San Diego."ANEclear is an important tool for anesthesia providers and recovery room caregivers to accelerate patient emergence in both the outpatient and inpatient setting," said Jeffrey M. Yordon, chief executive officer, founder and chairman of the board, Sagent Pharmaceuticals, Inc. "The launch of this innovative device further demonstrates Sagent's commitment to introducing unique solutions in response to the needs of caregivers and patients."
About Sagent Pharmaceuticals, Inc.
Sagent Pharmaceuticals, founded in 2006, is a privately held specialty pharmaceutical company focused on developing, manufacturing, sourcing and marketing pharmaceutical products, with a specific emphasis on injectable products. Sagent has created a unique, global network of resources, comprised of rapid development capabilities, sophisticated manufacturing and innovative drug-delivery technologies, quickly yielding an extensive portfolio of pharmaceutical products that fulfills the evolving needs of patients.
To Discover Injectables Excellence™ and learn more about Sagent, please visit www.SagentPharma.com.
To learn more about ANEclear, please visit www.ANEclear.com.
Source: Sagent Pharmaceuticals
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.